BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 17
• 18
• 19
• 20
• 21
• 22
• 24
• 25
• 26
• 27
• 28
• 29
• 30

• Business

  Ortho Clinical Diagnostics and Sphingotec Announce Strategic Agreement Regarding Novel Biomarker for Decreasing Re-hospitalizations in Heart Failure

  The agreement allows Ortho to use the sphingotest bio-ADM immunoassay on Ortho’s automated VITROS Immunodiagnostics and Integrated Systems for small, mid- and high-volume clinical laboratories.

  December 7, 2017

   · 

  4 min read
• Deals

  ImmunoPrecise to Acquire ModiQuest Research BV

  The Transaction continues to realize on the Board’s commitment to grow globally through strategic acquisitions.

  December 7, 2017

   · 

  5 min read
• Pharm Country

  Eisai and Purdue Pharma L.P. Presented Lemborexant Data From Research Studies at ACNP Annual Meeting

  The Asakura et al. poster presentation reported a non-clinical study demonstrating differences in lemborexant abuse liability when compared to a currently marketed insomnia treatment, suvorexant.

  December 7, 2017

   · 

  4 min read
• Biotech Bay

  Revance Announces Pricing of Public Offering of 5,338,709 shares of Common Stock

  Revance announced the pricing of an underwritten public offering of 5,338,709 shares of its common stock at a price to the public of $31.00 per share.

  December 7, 2017

   · 

  4 min read
• 

  Genetown

  Lumicell Bags $29M for Key Breast Cancer Trial and Expansion Into Other Cancers

  Existing and new investors, including Launch Capital and BlueIO participated in the financing.

  December 7, 2017

   · 

  3 min read
• Genetown

  Alcyone Lifesciences Announces First Pediatric Patient Treated with AMC for Treatment of DIPG

  The study is evaluating the safety and efficacy of single dose DNX-2401 delivered with Alcyone’s AMC system for pediatric patients with newly diagnosed DIPG at the Clínica Universidad de Navarra in Pamplona, Spain.

  December 7, 2017

   · 

  2 min read
• Business

  Hepa Wash Initiates Collaboration With German Accelerator Life Sciences to Prepare U.S. Expansion

  Hepa Wash’s U.S. expansion will be guided by a team of GALS mentors with profound commercial and technical expertise in the field of organ support.

  December 7, 2017

   · 

  4 min read
• Drug Development

  Concentric Analgesics Receives FDA Fast Track Designation for CA-008 for Post-Surgical Pain

  CA-008 is a proprietary water-soluble prodrug that converts into capsaicin, a potent TRPV-1 agonist.

  December 7, 2017

   · 

  3 min read
• Gecko Biomedical Builds Out Strategy For ‘Print On’ Polymers Platform

  Gecko’s proprietary technology platform is composed of fully synthetic light-activated polymers that can be ‘printed’ on living tissue inside and outside the body.

  December 7, 2017

   · 

  4 min read
• Business

  Lexington Hires Medical Device Reimbursement Experts

  Lexington Biosciences, a development-stage medical device company, is pleased to announce entry into a strategic business relationship with a San Francisco arm of Navigant Consulting Inc., formerly Quorum Consulting.

  December 7, 2017

   · 

  4 min read